Identification of calpain cleavage sites in the G1 cyclin-dependent kinase inhibitor p19INK4d

Biological Chemistry

Volumn 387, Issue 3, 2006, Pages 329-335

  Joy, Joma ^a   Nalabothula, Narasimharao ^a   Ghosh, Madhumita ^a   Popp, Oliver ^b   Jochum, Marianne ^b   Machleidt, Werner ^c   Gil Parrado, Shirley ^b,d   Holak, Tad A ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Calpain; Calpastatin; Cyclin dependent kinases; Nuclear magnetic resonance spectroscopy; p19INK4d; Proteolysis

Indexed keywords

ANKYRIN; CALPAIN; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P19;

ARTICLE; CELL CYCLE; COMPARATIVE STUDY; MAMMAL CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE;

MAMMALIA; VERTEBRATA;

EID: 33645030937     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.044     Document Type: Article

References (55)

1. Arora, A.S., DeGroen, P.C., Croall, D.E., Emori, Y., and Gores, G.J. (1996). Hepatocellular carcinoma cells resist necrosis during anoxia by preventing phospholipase-mediated calpain activation. J. Cell. Physiol. 167, 434-442.
2. Bates, S., Phillips, A.C., Clark, P.A., Stott, F., Peters, G., Ludwig, R.L., and Vousden, K.H. (1998). p14(ARF) links the tumour suppressors RB and p53. Nature 395, 124-125.
3. Bartek, J., Bartkova, J., and Lukas, J. (1997). The retinoblastoma protein pathway in cell cycle control and cancer. Exp. Cell Res. 237, 1-6.
4. Baumgartner, R., Fernandez-Catalan, C., Winoto, A., Huber, R., Engh, R.A., and Holak, T.A. (1998). Structure of human cyclin-dependent kinase inhibitor p19 (INK4d): comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16 (INK4a). Structure 6, 1279-1290.
5. Brotherton, D.H., Dhanaraj, V., Wick, S., Brizuela, L., Domaille, P.J., Volyanik, E., Xu, X., Parisini, E., Smith, B.O., Archer, S.J., et al. (1998). Crystal structure of the complex of the cyclin D dependent kinase Cdk6 bound to the cell-cycle inhibitor p19 (INK4d). Nature 395, 244-250.
6. Cheek, S., Zhang, H., and Grishin, N.V. (2002). Sequence and structure classification of kinases. J. Mol. Biol. 320, 855-881.
7. Choi, Y.H., Lee, S.J., Nguyen, P., Jang, J.S., Lee, J., Wu, M.L., Takano, E., Maki, M., Henkart, P.A., and Trepel, J.B. (1997). Regulation of cyclin D1 by calpain protease. J. Biol. Chem. 272, 28479-28484.
8. Croall, D.E. and Demartino, G.N. (1991). Calcium-activated neutral protease (calpain) system - structure, function, and regulation. Physiol. Rev. 71, 813-847.
9. Dayton, W.R., Schollmeyer, J.V., Lepley, R.A., and Cortes, L.R. (1981). A calcium-activated protease possibly involved in myofibrillar protein-turnover-isolation of a low-calcium-requiring form of the protease. Biochim. Biophys. Acta 659, 48-61.
10. De Gregore, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J.R. (1997). Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94, 7245-7250.
11. Du, X.P., Saido, T.C., Tsubuki, S., Indig, F.E., Williams, M.J., and Ginsberg, M.H. (1995). Calpain cleavage of the cytoplasmic domain of the integrin β3 subunit. J. Biol. Chem. 270, 26146-26151.
12. 2+ proteinase on murine vimentin, the mesenchymal intermediate filament protein. Biol. Chem. Hoppe-Seyler 367, 1147-1152.
13. Fuchs, E. and Weber, K. (1994). Intermediate filaments - structure, dynamics, function, and disease. Annu. Rev. Biochem. 63, 345-382.
14. Gabrijelcic-Geiger, D., Mentele, R., Meisel, B., Hinz, H., Assfalg-Machleidt, L., Machleidt, W., Moller, A., and Auerswald, E.A. (2001). Human μ-calpain: simple isolation from erythrocytes and characterization of autolysis fragments. Biol. Chem. 382, 1733-1737.
15. Ghosh, M., Shanker, S., Siwanowicz, I., Mann, K., Machleidt, W., and Holak, T.A. (2005). Proteolysis of insulin-like growth factor binding proteins (IGFBPs) by calpain. Biol. Chem. 386, 85-93.
16. Glading, A., Lauffenburger, D.A., and Wells, A. (2002). Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol. 12, 46-54.
17. Goll, D.E., Thompson, V.F., Li, H.Q., Wei, W., and Cong, J.Y. (2003). The calpain system. Physiol. Rev. 83, 731-801.
18. Harper, J.W. and Elledge, S.J. (1996). Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6, 56-64.
19. Harris, A.S., Croall, D.E., and Morrow, J.S. (1988). The calmodulin-binding site in α-fodrin is near the calcium-dependent protease-I cleavage site. J. Biol. Chem. 263, 15754-15761.
20. Huang, Y. and Wang, K.K. (2001). The calpain family and human disease. Trends Mol. Med. 7, 355-362.
21. Inomata, M., Hayashi, M., Nakamura, M., Saito, Y., and Kawashima, S. (1989). Properties of erythrocyte-membrane binding and autolytic activation of calcium-activated neutral protease. J. Biol. Chem. 264, 18838-18843.
22. Inomata, M., Saito, Y., Kon, K., and Kawashima, S. (1990). Binding-sites for calcium-activated neutral protease on erythrocyte membranes are not membrane phospholipids. Biochem. Biophys. Res. Commun. 171, 625-632.
23. Irwin, M., Marin, M.C., Phillips, A.C., Seelan, R.S., Smith, D.I., Liu, W.G., Flores, E.R., Tsai, K.Y., Jacks, T., Vousden, K.H., and Kaelin, W.G. (2000). Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407, 645-648.
24. Kalus, W., Baumgartner, R., and Renner, C., Noegel, A., Chan, F.K.M., Winoto, A., and Holak, T.A. (1997). NMR structural characterization of the CDK inhibitor p19 (INK4d). FEBS Lett. 401, 127-132.
25. Khorchid, A. and Ikura, M. (2002). How calpain is activated by calcium. Nat. Struct. Biol. 9, 239-241.
26. Kuboki, M., Ishii, H., and Kazama, M. (1987). Procalpain is activated on the plasma-membrane and the calpain acts on the membrane. Biochim. Biophys. Acta 929, 164-172.
27. Kuboki, M., Ishii, H., and Kazama, M. (1990). Characterization of calpain-I binding-proteins in human erythrocyte plasma-membrane. J. Biochem. 107, 776-780.
28. Lee, W.J., Adachi, Y., Maki, M., Hatanaka, M., and Murachi, T. (1990). Factors influencing the binding of calpain-I to human erythrocyte inside-out vesicles. Biochem. Int. 22, 163-171.
29. Leone, G., DeGregori, J., Yan, Z., Jakoi, L., Ishida, S., Williams, R.S., and Nevins, J.R. (1998). E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12, 2120-2130.
30. Li, H., Thompson, V.F., and Goll, D.E. (2004). Effects of autolysis and properties of μ-and m-calpain. Biochim. Biophys. Acta 1691, 91-103.
31. Mellgren, R.L. (1980). Canine cardiac calcium-dependent proteases - resolution of two forms with different requirements for calcium. FEBS Lett. 109, 129-133.
32. 2+ switch aligns the active site of calpain. Cell 108, 649-660.
33. Moldoveanu, T., Hosfield, C.M., Lim, D., Jia, Z., and Davies, P.L. (2003). Calpain silencing by a reversible intrinsic mechanism. Nat. Struct. Biol. 10, 371-378.
34. 2+- activated neutral protease is active in the erythrocyte-membrane in its nonautolyzed 80-kDa form. J. Biol. Chem. 269, 27992-27995.
35. Morgan, D.O. (1995). Principles of Cdk regulation. Nature 374, 131-134.
36. 2+ and the stimulation of a nonlysosomal proteolytic system. J. Biol. Chem. 261, 4628-4635.
37. 2+ requirement. Structure 11, 1521-1526.
38. Patel, Y.M. and Lane, M.D. (2000). Mitotic clonal expansion during preadipocyte differentiation: calpain-mediated turnover of p27. J. Biol. Chem. 275, 17653-17660.
39. Pavletich, N.P. (1999). Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J. Mol. Biol. 287, 821-828.
40. Pines, J. (1996). Cell cycle: reaching for a role for the CDKs proteins. Curr. Biol. 6, 1399-1402.
41. INK4d studied by N-15 NMR relaxation experiments at two field strengths. J. Mol. Biol. 283, 221-229.
42. INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1378, 115-177.
43. INK4a. Nature 395, 237-243.
44. Sasaki, T., Kikuchi, T., Yumoto, N., Yoshimura, N., and Murachi, T. (1984). Comparative specificity and kinetic-studies on porcine calpain-I and calpain-Ii with naturally-occurring peptides and synthetic fluorogenic substrates. J. Biol. Chem. 259, 2489-2494.
45. INK4a. Exp. Cell Res. 237, 7-13.
46. INK4a. Cell 88, 593-602.
47. 1-phase progression. Genes Dev. 13, 1501-1512.
48. Smialowski, P., Singh, M., Mikolajka, A., Majumdar, S., Joy, J.K., Nalabothula, N., Krajewski, M., Degenkolbe, R., Bernard, H.U., and Holak, T.A (2005). NMR and mass spectrometry studies of putative interactions of cell cycle proteins pRb and CDK6 with cell differentiation proteins MyoD and ID-2. Biochim. Biophys. Acta 1750, 48-60.
49. Spencer, M.J., Croall, D.E., and Tidball, J.G. (1995). Calpains are activated in necrotic fibers from Mdx dystrophic mice. J. Biol. Chem. 270, 10909-10914.
50. Stabach, P.R., Cianci, C.D., Glantz, S.B., Zhang, Z.S., and Morrow, J.S. (1997). Site-directed mutagenesis of αII spectrin at codon 1175 modulates its μ-calpain susceptibility. Biochemistry 36, 57-65.
51. Strelkov, S.V., Herrmann, H., Geisler, N., Wedig, T., Zimbelmann, R., Aebi, U., and Burkhard, P. (2002). Conserved segments 1A and 2B of the intermediate filament dimer: their atomic structures and role in filament assembly. EMBO J. 21, 1255-1266.
52. Tompa, P. and Friedrich, P. (2000). Kinetic analysis of human μ-calpain autolysis. In: Calpain Methods and Protocols, J.S. Elce, ed. (Totowa, NJ, USA: Humana Press), pp. 129-136.
53. Tsutsumi, M., Tsai, Y.C., Gonzalgo, M.L., Nichols, P.W., and Jones, P.A. (1998). Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer. Oncogene 17, 3021-3027.
54. Weinberg, R.A. (1995). The retinoblastoma protein and cell-cycle control. Cell 81, 323-330.
55. Ink4d. Mol. Cell. Biol. 9, 3244-3255.